Feedback / Questions
ALK-201 - Allink Biotherapeutics
ALK-202 - Allink Biotherapeutics
https://www.prnewswire.com/news-releases/allink-biotherapeutics-raises-42m-series-a-financing-to-accelerate-global-development-of-bispecific-antibody-and-adc-pipeline-302318081.html
Nov 28, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next